Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Texas court decision on Dow Chemical breast implant liability could affect federal ruling.

This article was originally published in The Gray Sheet

Executive Summary

TEXAS COURT RULING ON DOW CHEMICAL BREAST IMPLANT LIABILITY could influence the Alabama District Court's ruling on whether to exempt the firm from product liability related to Dow Corning silicone breast implants. In the Texas case, a jury on Feb. 15 found both Dow Corning and Dow Chemical liable for damages. Judge Michael Schneider is reviewing the jury's finding and is expected to make a final ruling in the next two weeks.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT003502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel